Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Exocrine Neoplasm”

53 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 53 results

Post-approval studies (Phase 4)Looking for participantsNCT06099119
What this trial is testing

Efficacy of PERT for PEI in Unresectable Pancreatic Cancer.

Who this might be right for
Unresectable Pancreatic Cancer
Hospital Clinico Universitario de Santiago 100
Not applicableStudy completedNCT04406571
What this trial is testing

Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
CHU de Reims 700
Early research (Phase 1)Study completedNCT01918644
What this trial is testing

Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer

Who this might be right for
Stage IA Pancreatic CancerStage IB Pancreatic CancerStage IIA Pancreatic Cancer+1 more
University of Wisconsin, Madison 21
Early research (Phase 1)Study completedNCT01385956
What this trial is testing

SOM 230 and Gemcitabine in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute 20
Not applicableTemporarily pausedNCT04306939
What this trial is testing

Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study

Who this might be right for
Chronic PancreatitisInflammatory Bowel DiseasesHepatitis+24 more
University of Pittsburgh 120,000
Early research (Phase 1)Looking for participantsNCT04389632
What this trial is testing

Sigvotatug Vedotin in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckHER2 Negative Breast Neoplasms+9 more
Seagen, a wholly owned subsidiary of Pfizer 1,006
Testing effectiveness (Phase 2)UnknownNCT01728818
What this trial is testing

Afatinib as Cancer Therapy for Exocrine Pancreatic Tumours

Who this might be right for
Focus of Study Instead
PD Dr. med. Volker Heinemann 119
Testing effectiveness (Phase 2)Active Not RecruitingNCT02061800
What this trial is testing

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Who this might be right for
Chronic Myeloid Leukemia (CML)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)+3 more
Diane George 14
Large-scale testing (Phase 3)Study completedNCT00416507
What this trial is testing

Gemcitabine With or Without Combination Chemotherapy and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Who this might be right for
Pancreatic Cancer
Federation Francophone de Cancerologie Digestive 190
Not applicableStudy completedNCT07182136
What this trial is testing

The Impact of Hepatic Steatosis on Survival After Pancreaticoduodenectomy

Who this might be right for
Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy
Wei-Hsun Lu 200
Testing effectiveness (Phase 2)Ended earlyNCT02985801
What this trial is testing

PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic InsufficiencyPancreatic CancerPancreatic Enzyme Abnormality
Massimo Raimondo, M.D. 16
Early research (Phase 1)Study completedNCT00220649
What this trial is testing

Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Neoplasms
St. Luke's-Roosevelt Hospital Center 25
Not applicableLooking for participantsNCT06651580
What this trial is testing

Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study

Who this might be right for
Chronic PancreatitisExocrine Pancreas CarcinomaRecurrent Acute Pancreatitis
M.D. Anderson Cancer Center 1,600
Not applicableLooking for participantsNCT04011982
What this trial is testing

PATAKESS Protocol : Clinical and Biological Analysis of Exocrine Pancreatic Tumors

Who this might be right for
Exocrine Pancreatic Cancer
Centre Leon Berard 300
Not applicableLooking for participantsNCT06056908
What this trial is testing

Shwachman Diamond Syndrome Registry and Study

Who this might be right for
Shwachman-Diamond SyndromeShwachman-Diamond Syndrome-Like
Boston Children's Hospital 5,000
Not applicableLooking for participantsNCT06422455
What this trial is testing

Access to Genetic Testing in Underserved Patients With Cancer

Who this might be right for
Breast CarcinomaMale Breast CarcinomaMalignant Solid Neoplasm+5 more
University of Southern California 800
Not applicableStudy completedNCT05687474
What this trial is testing

Baby Detect : Genomic Newborn Screening

Who this might be right for
Congenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more
Centre Hospitalier Universitaire de Liege 6,824
Not applicableUnknownNCT05244174
What this trial is testing

Impact of Pancreatic Endoscopic Drainage on Exocrine Pancreatic Function in Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasm Malignant Head PrimaryPancreatic Exocrine Insufficiency
Hospital Clinico Universitario de Santiago 82
Testing effectiveness (Phase 2)Study completedNCT03738787
What this trial is testing

Treatment of the Pancreatic Stump With Neoprene®-Based Glue After High-risk Pancreatoduodenectomy

Who this might be right for
Pancreatic FistulaPancreatic NeoplasmsPostoperative Complications
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 40
Early research (Phase 1)Study completedNCT03871959
What this trial is testing

Pembrolizumab In Combination With Debio 1143 In Pancreatic and Colorectal Advanced/Metastatic Adenocarcinoma

Who this might be right for
Adenocarcinoma of the PancreasAdenocarcinoma of the ColonAdenocarcinoma of the Rectum
Centre Leon Berard 54
Load More Results